{"title":"Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1","authors":"","doi":"10.1111/ajco.13997","DOIUrl":"10.1111/ajco.13997","url":null,"abstract":"<p><b>Retraction</b>: Zhang D, Zhang Y, Sun X. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1. <i>Asia-Pac J Clin Oncol</i>. 2021;17:253-263. https://doi.org/10.1111/ajco.13451. The above article, published online on 20 October 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editors-in-Chief, Professor Stephen Ackland and Professor Mengzhao Wang, and John Wiley & Sons Australia, Ltd. Following publication, concerns were raised by third parties regarding possible image duplication within Figures 2, 4 and 6. Upon investigation by the editorial team, it was concluded that several image elements of the experimental data were duplicated within figures in the article, or had already been published elsewhere in a different scientific context. Thus, the editors consider the conclusions of this article to no longer be reliable.</p>","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.13997","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Author Listing","authors":"","doi":"10.1111/ajco.14027","DOIUrl":"https://doi.org/10.1111/ajco.14027","url":null,"abstract":"<p>Abo, S 237,59</p><p>Abousamra, A 433</p><p>Ackerman, I 253</p><p>Ackland, T 53</p><p>Adam, T 358</p><p>Adams, C 139</p><p>Adams, D 377</p><p>Adams, G 233</p><p>Adams, J 254</p><p>Adams, K 188</p><p>Adderley, H 42</p><p>Adlard, KN 198</p><p>Aga, A 189</p><p>Agar, M 164,356,433,434,450,451,452,514</p><p>Agar, MR 497</p><p>Ahern, E 305,306</p><p>Ahmadi, N 170,170,171,171</p><p>Ahmed, E 243</p><p>Ahn, M 199</p><p>Aitken, J 104,50</p><p>Aitken, JF 501</p><p>Akechi, T 491</p><p>Akhurst, T 515</p><p>Al Deleemy, M 219</p><p>Al-Mufti, T 300,318</p><p>Alamgeer, M 221</p><p>Alexander, H 314</p><p>Alexander, M 129,131,132</p><p>ALHulais, R 172</p><p>Allan, C 419</p><p>Allan, R 427</p><p>Allard, N 411</p><p>Allen, C 423</p><p>Allen, M 516</p><p>Allen, S 173</p><p>Alonso, M 200</p><p>Alsaid, H 78</p><p>Aly, A 180,187</p><p>Amgarth-Duff, I 450,497,514</p><p>Amil, A 415</p><p>Ananda, S 189</p><p>Anazodo, A 483</p><p>Andersen, S 407</p><p>Anderson, D 513</p><p>Anderson, H 288</p><p>Anderson, LE 160</p><p>Anderson, M 302</p><p>Anderson, W 30</p><p>Andree-Evarts, D 163,421,423</p><p>Andrew, C 449</p><p>Andrews, J 82</p><p>Angioli, R 174</p><p>Antill, YC 82</p><p>Antony, J 277</p><p>Arance, A 209</p><p>Aranda, S 83</p><p>Arendse, M 302</p><p>Arif, S 388</p><p>Ariyarathna, D 173</p><p>Arkadieff, K 416</p><p>Arneil, M 212</p><p>Arnolda, G 374</p><p>Arora, S 61</p><p>Arrington, D 263</p><p>Arulananda, S 178</p><p>Asadi, K 189</p><p>Ascierto, PA 209</p><p>Ashford, B 482</p><p>Ashwell, C 463</p><p>Ashwell, W 273</p><p>Aslam, M 301</p><p>Athan, S 128,129</p><p>Atkinson, V 212</p><p>Au-Yeung, G 117,364</p><p>Auchettl, J 412</p><p>Austen, M 93</p><p>Austin, E 373</p><p>Avery, S 194,370</p><p>Aye, P 302</p><p>Ayre, S 320</p><p>Ayub, Z 42</p><p>Aziez, A 78</p><p>Bagga, R 161</p><p>Bailey, E 74</p><p>Bailey, H 182</p><p>Bairstow, P 189</p><p>Baker, S 292</p><p>Baksa, S 429</p><p>Balaam, S 513</p><p>Balabhadrapatruni, C 78</p><p>Balachander, S 79</p><p>Balana, C 200</p><p>Baldwin, C 207</p><p>Ball, D 211</p><p>Ballinger, M 402</p><p>Bamgboje-Ayodele, A 277</p><p>Banerjee, A 174,78</p><p>Bang, A 23</p><p>Banks, E 52</p><p>Bansal, S 233</p><p>Baramidze, A 503</p><p>Bardia, A 248</p><p>Bareham, M 440,476</p><p>Barker, S 22</p><p>Barnes, J 302</p><p>Barnes, T 251</p><p>Barnett, F 333,395</p><p>Baron, A 216</p><p>Baron-Hay, S 196</p><p>Barratt, A 258</p><p>Barrios, C 248</p><p>Barry, JA 78</p><p>Bartle, J 510</p><p>Bartlett, S 281</p><p>Bartley, N 321,390</p><p>Barton, C 284</p><p>Barton, M 481,59</p><p>Bartula, I 424</p><p>Bastick, P 184</p><p>Bauer, J 208</p><p>Bauer, JD 164,239</p><p>Bauerschlag, D 174</p><p>Baxi, S 490</p><p>Baxter, K 412</p><p>Bayes, S 369</p><p>Beale, GK 175</p><p>Beaton, S 441</p><p>Beaton, SS 442</p><p>Beattie, A 136</p><p>Beatty, L 134,166,261,277,312,383,445,467,473</p><p>Beaven, C 176,177</p><p>Bechelli, M 178</p><p>Bejjani, C 433</p><p>Bekaii-Saab, T 101</p><p>Bell, K 164,243</p><p>Bell, R 133</p><p>Bellmunt, J 241</p><p>Benge, S 513</p><p>Bennett, G ","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68180156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Poster Listing","authors":"","doi":"10.1111/ajco.14024","DOIUrl":"10.1111/ajco.14024","url":null,"abstract":"<p><b>Leah Zajdlewicz</b></p><p>Decisions and prompts to screen for cervical, bowel, and breast cancer <i>abs# 160</i></p><p><b>Shalmoli Bhattacharyya</b></p><p>Cancer-associated mesenchymal stem cells promote proliferation in chemo-radio-resistant cervical cancer cells <i>abs# 161</i></p><p><b>Carina Chan</b></p><p>Identifying MET exon 14 skipping mutations in squamous cell lung cancer patients <i>abs# 162</i></p><p><b>Zoe Clarke</b></p><p>Medical imaging simulated radiation therapy: Improving access to palliative radiation therapy in WNSWLHD <i>abs# 163</i></p><p><b>Merran Findlay</b></p><p>Dashboards to deliver data-driven dietetics in the digital age: Translation of evidence-based nutrition guidelines into practice <i>abs# 164</i></p><p><b>Subhash Gupta</b></p><p>Emerging therapeutic potential of Vardhamana Pippali Rasayana (Ayurvedic drug) in breast cancer <i>abs# 165</i></p><p><b>Morgan Leske</b></p><p>Feasibility and preliminary efficacy of brief coaching calls in Healthy Living after Cancer Online: A randomized control trial <i>abs# 166</i></p><p><b>Ashley Macleod</b></p><p>Investigating LGBTIQA+ Inclusion in Victorian Cancer Care: An incomplete picture <i>abs# 167</i></p><p><b>Georgios Mavropalias</b></p><p>Implementation of eccentric exercise programs as therapy during cancer – A scoping review <i>abs# 168</i></p><p><b>Geoffrey Yuet Mun Wong</b></p><p>Genomic profiling and biomarker discovery for predicting early intrahepatic recurrence following resection of colorectal liver metastases <i>abs# 169</i></p><p><b>Navid Ahmadi</b></p><p>Perioperative and oncological outcomes of patients undergoing post-chemotherapy robotic-retroperitoneal lymph node dissection for management of primary testicular cancer <i>abs# 170</i></p><p><b>Navid Ahmadi</b></p><p>Perioperative and oncological outcomes of patients undergoing primary robotic-RPLND for management of primary testicular cancer <i>abs# 171</i></p><p><b>Reem ALHulais</b></p><p>Efficacy of celecoxib as an anticancer drug examined in the murine CT26 metastatic colorectal cancer model <i>abs# 172</i></p><p><b>Dinuka Ariyarathna</b></p><p>Providing early access to geriatric oncology services in a regional cancer center – An evaluation of a newly established Nurse-Navigator led Geriatric Oncology Service Model and associated safety outcomes <i>abs# 173</i></p><p><b>Ashish Banerjee</b></p><p>Dostarlimab for Primary Advanced or Recurrent (A/R) Endometrial Cancer (EC): Outcomes by Blinded Independent Central Review (BICR) of the RUBY trial <i>abs# 174</i></p><p><b>Greta K Beale</b></p><p>Association between clinical outcomes and PSMA PET metrics in patients with metastatic prostate cancer <i>abs# 175</i></p><p><b>Cassie Beaven</b></p><p>Immunotherapy in the setting of metastatic cutaneous squamous cell carcinoma – An OncoGeriatrics Perspective <i>abs# 176</i></p><p><b>Cassie Beaven</b></p><p>An evaluation of time to treatment with adjuvant chemotherapy in high-risk early breast cancer patients in a r","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Program in Detail","authors":"","doi":"10.1111/ajco.14023","DOIUrl":"10.1111/ajco.14023","url":null,"abstract":"<p>\u0000 \u0000 </p><p><b>Empowering excellence: advancing the quality and safety of gynaecological cancer care in Queensland</b>\u0000 \u0000 </p><p>Chair: Rhett Morton</p><p>7:00 AM <b>Rhett Morton</b></p><p>Navigating the pathways: Patterns of care for all women with gynaecological cancer in Queensland <i>abs# 1</i></p><p>7:15 AM <b>Tamara Butler</b></p><p>Ensuring equity: Monitoring health outcomes for Queensland First Nations women with cervical and endometrial cancer <i>abs# 2</i></p><p>7:30 AM <b>Penny Mackenzie</b></p><p>Trends in the utilisation of brachytherapy in cervical cancer in Queensland: How do we compare? <i>abs# 3</i></p><p>7:45 AM <b>Shaun McGrath</b></p><p>Increased endometrial cancer rates: The link between obesity and endometrial cancer risk <i>abs# 4</i></p><p><i>Session sponsored by</i>\u0000 </p><p><b>Innovations in Implementing Nutrition and Exercise Evidence to Enhance Cancer Care and Outcomes</b>\u0000 \u0000 </p><p>Co-Chair: Jenelle Loeliger</p><p>Co-Chair: David Mizrahi</p><p>This session will include interactive Q&A with all speakers.</p><p><i>This breakfast session is sponsored by COSA, and delivered by the COSA Nutrition and Exercise and Cancer Groups</i> </p><p><b>Best of the Best Posters – Epidemiology</b>\u0000 \u0000 </p><p>Chair: Ashley Hopkins</p><p>Discussant: Rebecca Venchiarutti</p><p>7:15 AM <b>Maria Aslam</b></p><p>Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: A population-based cohort study <i>abs# 301</i></p><p>7:20 AM <b>Vicki Durston</b></p><p>Making metastatic breast cancer count: Barriers, enablers and key recommendations identified through expert interviews and a national roundtable <i>abs# 304</i></p><p>7:25 AM <b>Lucy Gately</b></p><p>Linking data from a brain cancer clinical registry (BRAIN) with the state-based registry of Births Deaths Marriages: Improving the quality of clinical registry survival data <i>abs# 305</i></p><p>7:30 AM <b>Huah Shin Ng</b></p><p>Patterns of mental health service utilisation in people with cancer compared with people without cancer: The Australian National Study of Mental Health and Wellbeing analysis <i>abs# 312</i></p><p>7:35 AM <b>Suzanne Poulgrain</b></p><p>Patterns of treatment and survival outcomes for people diagnosed with glioblastoma: A population-based study in Queensland <i>abs# 314</i></p><p>7:40 AM <b>Robert Power</b></p><p>Modifiable risk factors for cancer among people with Lynch syndrome: An international, cross-sectional survey <i>abs# 315</i></p><p>7:45 AM <b>Euan Walpole</b></p><p>Benchmarking statewide cancer data: A comparison of breast and gynaecological cancer care indicators between Victoria and Queensland <i>abs# 316</i></p><p><i>Session sponsored by</i> </p><p><b>Best of the Best Posters – Clinical Research & Supportive Care</b>\u0000 \u0000 </p><p>Chair: Laura Kirsten</p><p>Discussant: Desmond Yip</p><p>7:15 AM <b>Morgan Farley</","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Poster Abstracts","authors":"","doi":"10.1111/ajco.14026","DOIUrl":"https://doi.org/10.1111/ajco.14026","url":null,"abstract":"<p>Laura E Anderson<sup>1,2</sup>, Katelyn Collins<sup>1,3</sup>, Larry Myers<sup>1,3</sup>, Michael J Ireland<sup>3,4</sup>, Mariam Omar<sup>1</sup>, Allanah Drummond<sup>3</sup>, <span>Leah Zajdlewicz</span><sup>1</sup>, Belinda Goodwin<sup>1,4,5</sup></p><p><i><sup>1</sup>Cancer Council Queensland, Fortitude Valley, Queensland, Australia</i></p><p><i><sup>2</sup>National Centre for Youth Substance Use Research, The University of Queensland, St Lucia, Queensland, Australia</i></p><p><i><sup>3</sup>School of Psychology and Wellbeing, University of Southern Queensland, Springfield, Queensland, Australia</i></p><p><i><sup>4</sup>Centre for Health Research, University of Southern Queensland, Springfield, Queensland, Australia</i></p><p><i><sup>5</sup>Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Queensland, Australia</i></p><p><b>Aims</b>: Population-wide cancer screening programs save lives through early cancer detection; however, many people do not participate. We aimed to understand decision formation and prompts to action for screening behaviours to inform interventions to increase bowel, breast and cervical cancer screening uptake.</p><p><b>Methods</b>: Cancer screeners (<i>N</i> = 962) were asked what made them decide to screen and what prompted them to act through an online survey. Content analysis was used to capture the frequency of common responses. Interrater reliability was high (<i>κ</i> = .96, %agree = 97%).</p><p><b>Results</b>: For breast and cervical screening, decisions were commonly based on ‘screening being routine’ (32.58% – breast, 35.19% – cervical) or ‘receiving a reminder’ (20.53% – breast, 13.07% – cervical), and common prompts were ‘receiving a reminder’ (40.68% – breast, 29.13% – cervical), ‘screening being routine’ (22.05% breast, 18.65% cervical). Participants reported deciding to screen for bowel cancer due to ‘arrival of home screening test kit’ (40.50%) or the ‘experience of loved one's cancer’ (13.57%) and were prompted by ‘arrival of home test kit’ (23.58%), ‘convenience’ (15.72%) and the ‘desire to “get it over with”’ (10.22%). Importantly, approximately 25% of participants gave the same response to both the decision and prompt question.</p><p><b>Conclusions</b>: Interventions should target reminders and messages that support screening as part of regular healthcare routine, particularly for breast and cervical cancer screening. For bowel cancer screening, messaging should encourage immediate use of bowel cancer screening kits upon arrival. The messaging inviting individuals to screening programs should be carefully considered, as it often coincides with both the decision to participate and prompts action.</p><p><span>Shalmoli Bhattacharyya</span><sup>1</sup>, Sanchita Khurana<sup>1</sup>, Reena Sharma<sup>2</sup>, Bhavana Rai<sup>2</sup>, Rashmi Bagga<sup>3</sup></p><p><i><sup>1</sup>Biophysics, PGIMER, Chandigarh, India</i></p><p><i><sup>2</sup>Radiotherapy, PGIMER, Chandi","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68180145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Oral Abstracts","authors":"","doi":"10.1111/ajco.14025","DOIUrl":"https://doi.org/10.1111/ajco.14025","url":null,"abstract":"<p><span>Rhett Morton</span><sup>1</sup>, Marcelo Nascimento<sup>2</sup>, Penny Mackenzie<sup>1</sup>, Kathryn Middleton<sup>3</sup>, Shaun McGrath<sup>3</sup>, Anna Kuchel<sup>1</sup>, Danica Cossio<sup>4</sup>, Victoria Donoghue<sup>4</sup>, Karen Sanday<sup>5</sup>, Neal Rawson<sup>4</sup>, Euan Walpole<sup>4,6</sup>, Andrea Garrett<sup>1</sup></p><p><i><sup>1</sup>Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia</i></p><p><i><sup>2</sup>Gold Coast University Hospital, Gold Coast, Queensland, Australia</i></p><p><i><sup>3</sup>Mater Hospital Brisbane, Brisbane, Queensland, Australia</i></p><p><i><sup>4</sup>Cancer Alliance Queensland, Wooloongabba, Queensland, Australia</i></p><p><i><sup>5</sup>Queensland Centre for Gynaecological Cancer, Brisbane, Queensland, Australia</i></p><p><i><sup>6</sup>Princess Alexandra Hospital, Brisbane, Queensland, Australia</i></p><p><b>Aims</b>: To understand the patterns of treatment for gynecological cancers (GC) across Queensland between 2012 and 2021 and look for areas of improvement.</p><p><b>Methods</b>: The source of population data for this study is the Queensland Oncology Repository (QOR), which is a comprehensive clinical cancer database that links diagnostic information from the Queensland Cancer Register (QCR), with treatment data (radiation therapy, surgery, and intravenous systemic therapy), admissions data for both public and private hospitals, and patient outcome data. Clinical data including FIGO stage and biomarkers was extracted from the Queensland Centre for Gynaecological Cancer database and linked to QOR.</p><p><b>Results: </b> A total of 11,909 Queensland women were diagnosed with GC between 2012 and 2021. The most common diagnosis is endometrial (45%, <i>n</i> = 5378) followed by ovarian (29%, <i>n</i> = 3453) and then cervical (18%, <i>n</i> = 2127) with the three making up 92% of all GC.</p><p>Women with GC typically require a multidisciplinary approach to their care, including surgery, radiation therapy, and systemic therapy. The overall treatment rate is high at 88% (<i>n</i> = 10,423/11,909). 73% of all GC diagnoses underwent resection with endometrial cancer having the highest resection rate of 84%. Radiation therapy treatment rates were highest for cervical cancer (47%), while systemic therapy rates were highest (70%) for ovarian cancer.</p><p>Small increases in the radiation therapy treatment rate between 2012 and 2016 and 2017 and 2021 were observed for endometrial (22%–26%) and vulval (29%–35%) cancers.</p><p>Survival for GC varies across the individual primary sites with endometrial cancer survival at 5 years 78% compared to ovarian at 44%.</p><p><b>Conclusion: </b> Accessing linked population-wide data enables active monitoring of care patterns for women with GC. This resource facilitates the extraction of valuable insights and evaluation of effective strategies and interventions to prevent, detect, diagnose, and treat GC. </p><p><span>Tamara Butler</sp","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68180718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"COSA committees","authors":"","doi":"10.1111/ajco.14018","DOIUrl":"10.1111/ajco.14018","url":null,"abstract":"<p>\u0000 \u0000 </p><p>A/Professor Dion Forstner – President</p><p>Professor Sabe Sabesan – President Elect</p><p>Ms Sandie Angus</p><p>Professor Judy Bauer</p><p>Professor Tanya Buchanan</p><p>Clinical A/Professor Merran Findlay (commenced March 2023)</p><p>Mr Peter Hooker</p><p>Dr Malinda Itchins</p><p>Professor Michael Jefford</p><p>Professor Tim Price</p><p>A/Professor Christopher Steer</p><p>A/Professor Dion Forstner – President</p><p>Professor Sabe Sabesan – President Elect</p><p>Professor Fran Boyle AM – Immediate Past President</p><p>Professor Meera Agar – Geriatric Oncology</p><p>A/Professor Arun Azad – Urologic Oncology</p><p>Ms Kathy Bell – Consumer Representative</p><p>Dr David Chan – Neuroendocrine Tumours</p><p>Professor Raymond Chan – Cancer Survivorship</p><p>Dr Connie Diakos – Gastrointestinal Cancer</p><p>Dr Susan Fraser – Breast Cancer</p><p>Professor Gail Garvey – First Nations Representative</p><p>Dr Ashley Hopkins – Epidemiology</p><p>Dr Malinda Itchins – Lung Cancer</p><p>Dr Laura Kirsten – Psycho-Oncology</p><p>Dr Andrea Knox – Advanced Trainee Representative (resigned April 2023)</p><p>Ms Merran Findlay – Nutrition (resigned March 2023)</p><p>Dr Eng-Siew Koh – Neuro-Oncology</p><p>Dr Judith Lacey – Integrative Oncology</p><p>Dr Wei-Sen Lam – Regional and Rural</p><p>Ms Jenelle Loeliger – Nutrition (commenced April 2023)</p><p>A/Professor Alex Menzies – Melanoma and Skin Cancer (resigned March 2023)</p><p>Professor Linda Mileshkin – Gynaecological Cancer</p><p>Dr David Mizrahi – Exercise and Cancer</p><p>Dr Wayne Nicholls – Adolescent and Young Adult</p><p>Dr Sophie Nightingale – Surgical Oncology</p><p>Professor Jane Phillips – Palliative Care</p><p>Ms Marissa Ryan – Cancer Pharmacists (Co-Chair)</p><p>Dr Geeta Sandhu – Cancer Pharmacists (Co-Chair)</p><p>Professor Clare Scott AM – Rare Cancers</p><p>Professor Bernard Stewart AM – Cancer Prevention</p><p>Mr Adam Stoneley – Clinical Trials and Research Professionals</p><p>Mr Simon Troth – Cancer Genetics</p><p>Dr Paul Viray – Advanced Trainee Representative (commenced June 2023)</p><p>Distinguished Professor Patsy Yates AM – Cancer Care Coordination</p><p>Professor Desmond Yip – Global Oncology</p><p>Ms Leonie Young – Consumer Representative</p><p>Professor Nik Zeps – Cancer Biology</p><p>Ms Marie Malica – Chief Executive Officer</p><p>Australasian Gastro-Intestinal Trials Group – Professor Tim Price</p><p>Australasian Leukaemia & Lymphoma Group – Professor Judith Trotman</p><p>Australia & New Zealand Sarcoma Association – Professor Angela Hong</p><p>Australian and New Zealand Children's Haematology/Oncology Group – Dr Nick Gottardo</p><p>Australia New Zealand Gynaecology Oncology Group – Professor Clare Scott AM</p><p>Australia and New Zealand Head & Neck Cancer Society – Dr Tsien Fua</p><p>Australia and New Zealand Urogenital & Prostate Cancer Trials Group – Professor Ian Davis</p><p>Breast Cancer Trials – Professor Sunil Lakhani</p><p>Cancer","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"National speakers","authors":"","doi":"10.1111/ajco.14021","DOIUrl":"10.1111/ajco.14021","url":null,"abstract":"<p></p><p><b>Dr George Au-Yeung</b></p><p><i>Peter MacCallum Cancer Centre</i></p><p>Dr George Au-Yeung is a clinician-researcher at Peter MacCallum Cancer Centre, and has a research interests in molecular biology of ovarian cancer as well as running novel biomarker driven clinical trials and translational research. He completed his PhD in Professor David Bowtell's laboratory, investigating novel therapeutic strategies for Cyclin E1 amplified high grade serous ovarian cancer, a subset of ovarian cancers that behave aggressively and lack treatment options. He is now a full-time medical oncologist at Peter Mac, working across the Gynae-Oncology and Melanoma service, and is Co-Deputy Director of Medical Oncology. He is an active member of ANZGOG, and holds current and former positions with the Royal Australasian College of Physicians (RACP) and the Medical Oncology Group of Australia (MOGA).</p><p></p><p><b>Kira Bloomquist</b></p><p><i>Griffith University, UCSF, Copenhagen University Hospital</i></p><p>I am a physical therapist and research fellow, currently affiliated with the University Hospitals Centre for Health Research (UCSF), Copenhagen University Hospital, Rigshospitalet, Denmark and Menzies Health Institute Queensland, Griffith University. My main areas of interest relate to “cancer survivorship” and draw on personal hands-on experiences with cancer survivors as a physical therapist since 1999, as well as experiences gained while undertaking various research roles (e.g., data collector, research assistant, and primary investigator) since 2003. My specific expertise relates to understanding the physical and psychosocial concerns faced following cancer, in particular lymphedema, and the role of exercise in cancer recovery.</p><p></p><p><b>A/Prof Anna Boltong</b></p><p><i>Cancer Australia</i></p><p>Associate Professor Anna Boltong is the Head of the Cancer Control Strategy Branch at Cancer Australia. A dietitian by training, Anna's background spans domestic and international leadership in clinical oncology, supportive care research, policy development, health inequalities, and education. At Cancer Australia, Anna oversees the development and implementation of the Australian Cancer Plan as well as the Optimal Care Systems and Indigenous Cancer Control portfolios.</p><p></p><p><b>A/Prof Angie Bone</b></p><p><i>Monash University</i></p><p>Angie is an Associate Professor of Practice in planetary health at the Monash Sustainable Development Institute, where she focuses on system transformation for health sector resilience and sustainability, behaviour change and planetary health. She is a senior public health physician and former Deputy Chief Health Officer in Victoria, with over 15 years of public health leadership and research experience on environmental influences on health and health equity. Angie works with a range of disciplines across the research/policy/practice interface, providing public health technical expertise combined with policy and","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Highlighted lectures and awards 2023","authors":"","doi":"10.1111/ajco.14019","DOIUrl":"10.1111/ajco.14019","url":null,"abstract":"<p><b>TOM REEVE AWARD FOR OUTSTANDING CONTRIBUTIONS TO CANCER CARE</b></p><p>This respected award, offered by COSA, formally recognises a national leader who has made a significant contribution over a relatively long period toward cancer care through research, clinical leadership, and/or community service. The award presentation and recipient's oration highlighting an overview of career achievements will be delivered Thursday 2 November at 1:30 pm.</p><p>COSA is proud to announce the 2023 recipient of the Tom Reeve Award for outstanding contributions to cancer care is <b>Dr David Speakman OAM</b>.</p><p>Past recipients include:</p><p>2022 Professor John Thompson AO</p><p>2021 Professor Michael Barton OAM</p><p>2020 Professor Sanchia Aranda AM</p><p>2019 Professor Ian Olver AM</p><p>2018 Professor Grant McArthur</p><p>2017 Emeritus Professor William H. McCarthy AM</p><p>2016 Professor Fran Boyle AM</p><p>2015 Professor David Currow</p><p>2014 Professor John Zalcberg OAM</p><p>2013 Professor Ian Frazer AC</p><p>2012 Professor David Ball AO</p><p>2011 Professor Phyllis Butow AM</p><p>2010 Professor John Forbes AM</p><p>2009 Professor Patsy Yates AM</p><p>2008 Professor Lester Peters AM</p><p>2007 Professor Martin Tattersall AO</p><p>2006 Professor Alan Coates AM</p><p>2005 (Inaugural Award) Professor Tom Reeve AC CBE</p><p></p><p><b>Tom Reeve AC CBE</b> was Emeritus Professor in Surgery of the University of Sydney, graduating in 1947. After working in Sydney and North Queensland, he went to Albany Medical College, upstate New York to complete training in General and Thoracic Surgery. In 1958, Prof. Reeve became certified with the American Board of Surgery and in 1967 became a Fellow of the Royal Australasian College of Surgeons. He was Chairman of Surgery at The University of Sydney from 1982 to 1988 and chaired the Northern Sydney Health Area from 1988 to 1996. On retirement, Prof. Reeve became President of the Royal Australasian College of Surgeons and was appointed Executive Officer of the Australian Cancer Network in late 1993. In this role, Prof. Reeve was involved in the development of Best Practice Guidelines in Cancer Management and the development of “Clinical Guidelines for the Management of Early Breast Cancer” for the NHMRC. These were the first evidence-based cancer management guidelines produced in Australia. Tom was a member of the Boards of Management of the NHMRC National Breast Cancer Centre and the National Cancer Control Initiative.</p><p>It was with great sadness that we learnt of the passing of Tom on August 20, 2023. This year's Tom Reeve Award and oration at the ASM will carry an additional poignancy.</p><p>3:00 pm, Friday 3 November</p><p>The COSA Presidential Lecture was introduced in 2010 and is an opportunity for our organisation to recognise the contribution of an individual to medical research, and for the COSA membership to be informed of and learn about that individual's work. COSA is delighted that Professor Bogda Ko","PeriodicalId":8633,"journal":{"name":"Asia-Pacific journal of clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajco.14019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
